AQR Capital Management - KITE PHARMA INC ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of KITE PHARMA INC
ValueSharesWeighting
Q3 2017$9,253,000
+340.6%
51,461
+154.0%
0.01%
+266.7%
Q2 2017$2,100,000
+510.5%
20,259
+229.4%
0.00%
+200.0%
Q3 2016$344,000
+11.7%
6,1500.0%0.00%0.0%
Q2 2016$308,000
-13.2%
6,150
-20.5%
0.00%0.0%
Q1 2016$355,000
-81.8%
7,740
-75.5%
0.00%
-66.7%
Q4 2015$1,951,000
-20.0%
31,656
-27.7%
0.00%
-40.0%
Q3 2015$2,438,000
+372.5%
43,795
+417.8%
0.01%
+400.0%
Q2 2015$516,0008,4580.00%
Other shareholders
KITE PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,358,084$105,736,00048.63%
BAINCO INTERNATIONAL INVESTORS 1,151,540$51,635,0008.76%
Coastal Bridge Advisors, LLC 250,040$11,212,0004.36%
NEXTHERA CAPITAL LP 150,000$6,726,0003.94%
Casdin Capital, LLC 94,000$4,215,0003.48%
MENORA MIVTACHIM HOLDINGS LTD. 1,258,899$56,449,0002.90%
DIALECTIC CAPITAL MANAGEMENT, LP 85,000$3,812,0002.14%
SECTORAL ASSET MANAGEMENT INC 372,223$16,690,0001.85%
ARK Investment Management 97,313$4,364,0001.59%
BB BIOTECH AG 800,000$35,872,0001.33%
View complete list of KITE PHARMA INC shareholders